~18 spots leftby Oct 2025

Intensive Infant Rehabilitation for Perinatal Stroke

(I-ACQUIRE Trial)

Recruiting in Palo Alto (17 mi)
+16 other locations
Overseen BySharon L Ramey, Ph.D.
Age: < 18
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 3
Waitlist Available
Sponsor: Virginia Polytechnic Institute and State University
No Placebo Group
Pivotal Trial (Near Approval)
Prior Safety Data

Trial Summary

What is the purpose of this trial?This trial is testing a new therapy program called I-ACQUIRE for infants who have had a stroke. The program involves intensive sessions with therapists to help improve movement and strength. The study will compare two different amounts of therapy to usual treatments to see which works best.

Eligibility Criteria

This trial is for infants aged 8-36 months who have had a Perinatal Arterial Stroke, resulting in hemiparesis. They must not have received certain previous treatments like high-dose movement therapy or botulinum toxin within the last three months. One parent must be English-speaking to interact with study staff and manage home therapy.

Inclusion Criteria

My child has weakness on one side of their body.
My parent(s) agree to be part of the home therapy.
My child was diagnosed with a stroke that occurred around the time of birth.
+3 more

Exclusion Criteria

My child was given botulinum toxin in the last 3 months.
My child has undergone intensive movement therapy for at least 2 hours a day over 10 days.
My child's health condition prevents them from fully participating in therapy.
+1 more

Participant Groups

The trial tests two different doses of a new infant rehabilitation protocol called I-ACQUIRE against standard rehab methods for babies who've had strokes. It aims to see which dosage improves motor skills better.
3Treatment groups
Experimental Treatment
Active Control
Group I: I-ACQUIRE Moderate DoseExperimental Treatment1 Intervention
Moderate Dose I-ACQUIRE (3 hrs/day, 5 day/wk X 4 wks)
Group II: I-ACQUIRE High DoseExperimental Treatment1 Intervention
High Dose I-ACQUIRE (6hrs/day, 5 days/wk X 4 wks)
Group III: Usual & Customary TreatmentActive Control1 Intervention
Usual \& Customary Treatment

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
University of Wisconsin School of Medicine and Public HealthMadison, WI
Children's Hospital of AlabamaBirmingham, AL
Scottish Rite for Children - DallasDallas, TX
Washington University School of Medicine, St. Louis Children's HospitalSt. Louis, MO
More Trial Locations
Loading ...

Who Is Running the Clinical Trial?

Virginia Polytechnic Institute and State UniversityLead Sponsor
Ohio State UniversityCollaborator
Nationwide Children's HospitalCollaborator
Stanford UniversityCollaborator
University of CincinnatiCollaborator
Medical University of South CarolinaCollaborator

References